Sanmina Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8010561020
USD
160.76
6.61 (4.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

545.52 k

Shareholding (Mar 2025)

FII

10.22%

Held by 138 FIIs

DII

31.85%

Held by 65 DIIs

Promoter

0.00%

How big is Sanmina Corp.?

22-Jun-2025

As of Jun 18, Sanmina Corp. has a market capitalization of $8.71 billion, with net sales of $7.85 billion and a net profit of $263.48 million over the latest four quarters.

Market Cap: As of Jun 18, Sanmina Corp. has a market capitalization of 8,708.37 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Sanmina Corp. reported net sales of 7,849.37 million and a net profit of 263.48 million.<BR><BR>Balance Sheet Snapshot: As of Sep 24, the company reported shareholder's funds of 2,196.62 million and total assets of 4,822.85 million.

Read More

What does Sanmina Corp. do?

22-Jun-2025

Sanmina Corporation provides integrated manufacturing solutions and services in the Pharmaceuticals & Biotechnology industry, with net sales of $1.984 billion and a market cap of approximately $8.71 billion as of March 2025. Key metrics include a P/E ratio of 32.00 and a return on equity of 12.13%.

Overview: <BR>Sanmina Corporation is a provider of integrated manufacturing solutions, components, products, and repair, logistics, and after-market services in the Pharmaceuticals & Biotechnology industry, categorized as a mid-cap company.<BR><BR>Financial Snapshot: <BR>Net Sales: 1,984 Million (Quarterly Results - Mar 2025) <BR>Net Profit: 71 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 8,708.37 Million (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: 32.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.16 <BR>Return on Equity: 12.13% <BR>Price to Book: 3.93<BR><BR>Contact Details: <BR>Address: 2700 N 1st St, SAN JOSE CA: 95134-2015 <BR>Tel: ['1 408 9643500', '1 408 9643610'] <BR>Fax: 1 408 9643440

Read More

Should I buy, sell or hold Sanmina Corp.?

22-Jun-2025

Who are in the management team of Sanmina Corp.?

22-Jun-2025

As of March 2022, Sanmina Corp.'s management team includes Mr. Jure Sola as Chairman and CEO, with Ms. Jacquelyn Ward as Lead Independent Director and several Independent Directors: Mr. Eugene Delaney, Mr. John Goldsberry, Ms. Rita Lane, and Mr. Joseph Licata.

As of March 2022, the management team of Sanmina Corp. includes Mr. Jure Sola, who serves as the Chairman of the Board and Chief Executive Officer. Additionally, the board features Ms. Jacquelyn Ward as the Lead Independent Director, along with several Independent Directors: Mr. Eugene Delaney, Mr. John Goldsberry, Ms. Rita Lane, and Mr. Joseph Licata.

Read More

Is Sanmina Corp. overvalued or undervalued?

20-Sep-2025

As of July 28, 2025, Sanmina Corp. is considered very attractive and undervalued, with a P/E ratio of 32, strong performance outpacing the S&P 500, and metrics indicating a favorable position compared to peers.

As of 28 July 2025, the valuation grade for Sanmina Corp. has moved from attractive to very attractive, indicating a stronger position in the market. Based on the current metrics, the company appears to be undervalued, with a P/E ratio of 32, an EV to EBITDA of 17.00, and a Price to Book Value of 3.85. In comparison to peers, Sanmina's P/E ratio is significantly lower than that of Masimo Corp. at 179.74, while Globus Medical, Inc. shows a more favorable P/E of 18.37.<BR><BR>The company's performance has outpaced the S&P 500, with a year-to-date return of 57.75% compared to the S&P 500's 12.22%, and a one-year return of 74.59% against 17.14% for the index. This robust performance further supports the view that Sanmina Corp. is currently undervalued in the market.

Read More

Is Sanmina Corp. technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, Sanmina Corp. is in a bullish trend supported by positive MACD and moving averages, despite mixed signals from Dow Theory and OBV, and has significantly outperformed the S&P 500 year-to-date.

As of 4 September 2025, the technical trend for Sanmina Corp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also reflect a bullish stance in both time frames. Daily moving averages are bullish, while the KST is bullish on both weekly and monthly charts. However, the Dow Theory indicates a mildly bullish trend on the weekly and no trend on the monthly, and the OBV is mildly bearish on the weekly with no trend on the monthly.<BR><BR>Sanmina Corp. has shown strong performance compared to the S&P 500, with a year-to-date return of 57.75% versus 12.22% for the index, and a one-year return of 74.59% compared to 17.14%. Overall, the current technical stance is bullish, supported by multiple indicators, although some caution is warranted due to the mixed signals from Dow Theory and OBV.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROE of 13.67%

 
2

Company has a low Debt to Equity ratio (avg) at times

 
3

Positive results in Jun 25

4

With ROE of 12.13%, it has a attractive valuation with a 3.85 Price to Book Value

5

High Institutional Holdings at 100%

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 11,620 Million (Small Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.22

stock-summary
Return on Equity

12.73%

stock-summary
Price to Book

5.07

Revenue and Profits:
Net Sales:
2,042 Million
(Quarterly Results - Jun 2025)
Net Profit:
73 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
37.99%
0%
37.99%
6 Months
82.35%
0%
82.35%
1 Year
101.0%
0%
101.0%
2 Years
219.09%
0%
219.09%
3 Years
138.52%
0%
138.52%
4 Years
326.31%
0%
326.31%
5 Years
398.33%
0%
398.33%

Sanmina Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.90%
EBIT Growth (5y)
9.35%
EBIT to Interest (avg)
13.83
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
3.26
Tax Ratio
21.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
21.19%
ROE (avg)
13.67%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
3.85
EV to EBIT
22.75
EV to EBITDA
17.00
EV to Capital Employed
4.39
EV to Sales
1.04
PEG Ratio
14.44
Dividend Yield
NA
ROCE (Latest)
19.30%
ROE (Latest)
12.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 89 Schemes (57.84%)

Foreign Institutions

Held by 138 Foreign Institutions (10.22%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 2.90% vs -1.11% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 3.40% vs -0.56% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,041.60",
          "val2": "1,984.10",
          "chgp": "2.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "133.20",
          "val2": "120.80",
          "chgp": "10.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.00",
          "val2": "5.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.60",
          "val2": "-1.00",
          "chgp": "-660.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "72.90",
          "val2": "70.50",
          "chgp": "3.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "50.70%",
          "val2": "46.70%",
          "chgp": "0.40%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2024 is -15.30% vs 12.82% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2024 is -27.39% vs 36.23% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,568.30",
          "val2": "8,935.00",
          "chgp": "-15.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "468.10",
          "val2": "579.90",
          "chgp": "-19.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "29.20",
          "val2": "36.30",
          "chgp": "-19.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.20",
          "val2": "-6.10",
          "chgp": "-67.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "237.80",
          "val2": "327.50",
          "chgp": "-27.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "45.70%",
          "val2": "51.70%",
          "chgp": "-0.60%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
2,041.60
1,984.10
2.90%
Operating Profit (PBDIT) excl Other Income
133.20
120.80
10.26%
Interest
5.00
5.00
Exceptional Items
-7.60
-1.00
-660.00%
Consolidate Net Profit
72.90
70.50
3.40%
Operating Profit Margin (Excl OI)
50.70%
46.70%
0.40%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 2.90% vs -1.11% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 3.40% vs -0.56% in Mar 2025

Annual Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
7,568.30
8,935.00
-15.30%
Operating Profit (PBDIT) excl Other Income
468.10
579.90
-19.28%
Interest
29.20
36.30
-19.56%
Exceptional Items
-10.20
-6.10
-67.21%
Consolidate Net Profit
237.80
327.50
-27.39%
Operating Profit Margin (Excl OI)
45.70%
51.70%
-0.60%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2024 is -15.30% vs 12.82% in Sep 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2024 is -27.39% vs 36.23% in Sep 2023

stock-summaryCompany CV
About Sanmina Corp. stock-summary
stock-summary
Sanmina Corp.
Pharmaceuticals & Biotechnology
Sanmina Corporation is a provider of integrated manufacturing solutions, components, products and repair, logistics and after-market services. The Company provides its offerings primarily to original equipment manufacturers (OEMs) in various industries, including communications networks, storage, industrial, defense and aerospace, medical and energy. The Company operates through two businesses: Integrated Manufacturing Solutions (IMS) and Components, Products and Services (CPS). IMS consists of printed circuit board assembly and test, final system assembly and test, and direct-order-fulfillment. Its Components include interconnect systems and mechanical systems. Its Products include memory, radio frequency (RF), optical and microelectronics solutions, defense and aerospace products, storage solutions and cloud-based manufacturing execution software. Its Services include design, engineering, logistics and repair services.
Company Coordinates stock-summary
Company Details
2700 N 1st St , SAN JOSE CA : 95134-2015
stock-summary
Tel: 1 408 96435001 408 9643610
stock-summary
stock-summary
Registrar Details